Annual Forecast for Oxford Biomedica (2018)

Until recently, Oxford Biomedica shares (LSE:OXB) were going upwards, from the beginning of January to March, 2018. Before then, the market was ranging.

In the short-term, things are bearish. The ADX period 14 is at the level 30, suggesting a considerable amount of momentum in the market. The DM- is above the DM+ (bulls’ hegemony).

The MACD default parameters, has its histogram below the zero line, while it signal lines are still above the zero line, but heading downwards.

The short-term bearish correction in the market will eventually enable the MACD signal lines to go below the zero line, thus leading to a Bearish Confirmation Pattern in the market.

Then what starts like a bearish correction will translate into a strong bearish bias. The outlook on Oxford Biomedica is bearish for the year 2018.

Azeez Mustapha

Market Analyst, Trading Signals Provider and Coach

Trading realities: Trading realities 

  

Source: http://uk.advfn.com/newspaper/authors/azeez-mustapha

Buy and sell Perfect Money/Payeer/Epay; get funded quickly: www.ituglobalfx.com.ng

Start your journey to permanent success: http://www.tallinex.com/open-account?i=128521